In addition miR-218 may facilitate MDA-MB-231 breast cancer bone metastasis by up-regulating CXCR4, a chemokine receptor supporting breast cancer cell migration to bone and mediating tumor growth in bone. This evidence concerns the gene CXCR4 and breast carcinoma.